Results 131 to 140 of about 32,102 (275)

Trastuzumab Deruxtecan for HER2‐Low Metastatic Breast Cancer: Practical Considerations for Medical Oncologists and Pathologists in Australia

Asia-Pacific Journal of Clinical Oncology, Volume 22, Issue 3, Page 381-391, June 2026.
ABSTRACT Trastuzumab deruxtecan (T‐DXd) is a third‐generation, HER2‐targeting antibody‐drug conjugate that has been shown to significantly prolong overall survival, compared with standard chemotherapy, when used to treat patients who have “HER2‐low” (HER2 immunohistochemistry [IHC] score 1+; or HER2 IHC 2+ plus in situ hybridization‐negative ...
Andrew Redfern, Elgene Lim, Sunil Lakhani, Nirmala Pathmanathan, Sudarsha Selva‐Nayagam, Nicole McCarthy, Belinda Yeo, Benjamin Dessauvagie, Gelareh Farshid   +8 more
wiley   +1 more source

Impact of antiemetic steroid use on survival in small cell lung cancer patients receiving immune checkpoint inhibitors and chemotherapy

Scientific Reports
Immune checkpoint inhibitors (ICIs) combined with conventional cytotoxic agents have become the new standard of care for extensive-stage small cell lung cancer (SCLC).
Soh Mee Park, Jonghyun Jeong, Yu Jung Kim, Ju-Yeun Lee   +3 more
doaj   +1 more source

Downstream Treatment Burden and Health‐Care Utilization Following Initiation of GLP‐1 Receptor Agonists or SGLT2 Inhibitors in Type 2 Diabetes

Diabetes, Obesity and Metabolism, Volume 28, Issue 6, Page 5163-5173, June 2026.
ABSTRACT Aims Glucagon‐like peptide‐1 (GLP‐1) receptor agonists and sodium–glucose cotransporter 2 (SGLT2) inhibitors are widely used for the treatment of type 2 diabetes, yet their downstream consequences in routine clinical practice remain incompletely characterized.
Yazan Alhamdan, Jason C. Hsu, Christine Y. Lu   +2 more
wiley   +1 more source

How Does Symptom Management Affect Quality of Life in Palliative Care Patients? A Descriptive and Correlation Study

Scandinavian Journal of Caring Sciences, Volume 40, Issue 2, June 2026.
ABSTRACT Aims This study aimed to determine the relationship between symptom management and quality of life in palliative care patients. Methods Data was collected using the Patient Information Form, the Edmonton Symptom Assessment Scale (ESAS), and the EQ‐5D Quality of Life Scale.
Gülşah Çamcı, Sıdıka Oğuz, Gülsüm Betül Uçar, Pınar Yarman   +3 more
wiley   +1 more source

Adherence to ESMO clinical recommendations for prophylaxis of chemotherapy-induced nausea and vomiting [PDF]

, 2018
Background: We assessed adherence to the European Society of Medical Oncology (ESMO)/Multinational Association of Supportive Care in Cancer recommendations for prophylaxis of chemotherapy-induced nausea and vomiting (CINV) at our institution.
Aebi, Stefan, Burmeister, Henning, Fey, Martin, Gautschi, Oliver, Studer, Cristina   +4 more
core  

Comparison of Morbidity Between Sentinel Lymph Node Biopsy and Elective Neck Dissection in Dogs With Head and Neck Malignancies

Veterinary and Comparative Oncology, Volume 24, Issue 2, Page 313-323, June 2026.
ABSTRACT Elective neck dissection (END) and sentinel lymph node biopsy (SLNB) are suggested for nodal staging of canine head and neck malignancies (HNM). This study aims to compare the morbidity of END to SLNB. Seventy‐six client‐owned dogs with HNM that underwent END (n = 28) or SLNB (n = 48) in two institutions were retrospectively enrolled ...
Lavinia Elena Chiti, Dominique Leu, Roberta Ferrari, Ester Luconi, Patrizia Boracchi, Elisa Maria Gariboldi, Damiano Stefanello, Mirja Christine Nolff   +7 more
wiley   +1 more source

Cannabinoids and drug–drug pharmacokinetic interactions: Deciphering the risks

British Journal of Clinical Pharmacology, Volume 92, Issue 5, Page 1287-1308, May 2026.
The relationship between cannabinoids and mental health has become a major focus of scientific inquiry and public discourse. Cannabinoids are diverse chemical compounds from the Cannabis species that have been explored for their therapeutic applications in treating chronic pain, psychiatric and neurological conditions, such as depression, schizophrenia,
Paraskevi Papakyriakopoulou, Georgia Valsami, Georgios Ismailos   +2 more
wiley   +1 more source

Cooling down for going up: Could selective ‘brain chilling’ mitigate high‐altitude illness?

Experimental Physiology, EarlyView.
Adnan Haq, Damian M. Bailey
wiley   +1 more source

The Clinical Benefits of Nutritional Supplementation Across the Chemotherapy Journey in Cancer Patients: A Multicenter Prospective Cohort Study

Cancer Medicine, Volume 15, Issue 5, May 2026.
ABSTRACT Purpose This study aimed to explore the clinical benefits of receiving nutritional supplementation (NS) throughout the whole course of chemotherapy. Methods This multicenter prospective cohort study totally included 251 cancer patients requiring nutritional support and scheduled for chemotherapy.
Jia‐Xin Huang, Si‐Wei Xie, Hui‐Min Qu, Zhi‐Gang Feng, Xin‐Yi Wang, Jun Zhao, Quan‐Fu Li, Ying Jiang, Feng Chen, Jun Li, Shun‐Chun Yao, Ming‐Hui Zhang, Xian Shen, Xiao‐Dong Chen, Ning Li, Xi Zhang, Le Tian, Min Yang, Meng Tang, Chen‐Xin Song, Bao‐Hua Zou, Sheng‐Ling Qin, Rong Qin, Ming‐Hua Cong   +23 more
wiley   +1 more source

Finite‐Duration Venetoclax/Azacitidine Followed by Umbilical Cord Blood Infusion Improves Outcomes in Frail Elderly Patients With Untreated Acute Myeloid Leukemia—A Pilot Study

Cancer Medicine, Volume 15, Issue 5, -Not available-.
ABSTRACT Background Continuous venetoclax‐azacitidine (VA) therapy is currently the major intervention for elderly or unfit acute myeloid leukemia (AML) patients. However, moderate chemotherapy with finite‐duration VA could achieve comparable or superior efficacy to infinite‐duration VA.
Li Ye, Mixue Xie, Gaixiang Xu, Chen Mei, Chao Hu, Xinping Zhou, Yanling Ren, Liya Ma, Chunmei Yang, Jiejing Qian, Jie Jin, Hongyan Tong   +11 more
wiley   +1 more source